In his weekly clinical update, Dr. Griffin discusses the immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate, association between nose picking and SARS-CoV-2 incidence, a cohort study in hospital health care workers; effect of COVID-19 vaccination and booster on maternal-fetal outcomes, dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA, does monoclonal antibody treatment for COVID-19 impact short and long- term outcomes in a large generalizable population, persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation, core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a influenza A vaccine candidate (The Lancet)
• Association between nose picking and SARS-CoV-2 incidence (PLOSONE)
• Effect of COVID-19 vaccination and booster on maternal-fetal outcomes (Lancet Digital Health)
• Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status (The Lancet)
• Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes (BMJ)
• Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and inflammation (Angiogenesis)
• Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts (STM)
• Contribute to our Floating Doctors fundraiser at PWB
• Letters read on TWiV 1034
• Dr. Griffin’s COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]